v3 Template
S

Sangamo Therapeutics

Biotechnology / Genomic Medicine not specified ~520 employees
Founded
--
Employees (Est.)
~520
26 leaders known
Total Funding
$72.0M
Funding Rounds
3
Last Funding
2026-02-03

About Sangamo Therapeutics

Sangamo Therapeutics, Inc. is a biotechnology company pioneering the future of genomic medicine by using its deep scientific expertise and proprietary zinc finger technology to create genetic cures for patients with severe diseases where current treatments only manage symptoms.

Products & Services

Idiopathic Small Fiber Neuropathy (ST-503):A wholly-owned neurology program in preclinical or early clinical phases targeting chronic neuropathic pain.
Fabry Disease (Isaralgagene civaparvovec):A clinical program focused on gene therapy for adults with Fabry disease, with updated results from the Phase 1/2 STAAR study.
Tauopathies:A partnered neurology program with Genentech targeting tau-related disorders.
ALS/FTD:A partnered neurology program with Alexion for amyotrophic lateral sclerosis and frontotemporal dementia.
Huntington's Disease:A partnered neurology program with Takeda for Huntington's disease treatment.

Specialties

Zinc Finger Technology Genomic Cures Gene Therapy Neurology Oncology Blood-Brain Barrier Penetrant AAV Capsids Modular Integrase (MINT) Platform

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Underwritten Offering
T: -
FT: Underwritten Offering
A: 25000000
MR: -
FA: 25.0 Million
FAN: 25000000
D: 2026-02-03
FD: 2026-02-03
2 investors
2 RT: Underwritten Offering
T: -
FT: Underwritten Offering
A: 23000000
MR: -
FA: approximately $23.0 million
FAN: 23000000
D: 2025-05-12
FD: 2025-05-12
1 investors
3 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 24000000
MR: -
FA: 24.0 million
FAN: 24000000
D: 2024-03-22
FD: 2024-03-22
2 investors
Underwritten Offering Latest
2026-02-03
$25.0M
2 investors (Pro only)
Underwritten Offering 2025-05-12
$23.0M
Registered Direct Offering 2024-03-22
$24.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

B

Bryan

Music Teacher

L

Lori

Hospital Lab Technician

M

Matt

Fabry Disease Patient

E

Elizabeth

Fabry Disease

I

Israel

Hemophilia A

M

Miles

Water Polo Athlete

View 23 more team members with Pro

Unlock Full Team Directory

Recent News

Sangamo Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Genomic Medicine
Company Size
~520 employees (est.)
Locations
not specified
New Orleans, LA
San Diego, CA

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro